Moon Capital Management (Tennessee)’s AbbVie ABBV Stock Holding History

Moon Capital Management (Tennessee)’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	$3.48M	Buy	+35,449	New	+$3.12M	4.22%	9

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Moon Capital Management (Tennessee)'s ABBV Position: Q2 2020 in Review

Moon Capital Management (Tennessee) opened a new position in AbbVie (ABBV) in Q2 2020: 35,449 shares worth $3.48M. The stake represents 4.22% of the portfolio and ranks #9 among its holdings.

2,411 funds tracked by Wall St. Rank hold ABBV as of Q2 2020.

Moon Capital Management (Tennessee) held 35,449 shares of AbbVie worth $3.48M as of Q2 2020.
AbbVie was a new Moon Capital Management (Tennessee) position in Q2 2020.
AbbVie made up 4.22% of Moon Capital Management (Tennessee)'s portfolio in Q2 2020, its #9 holding.
2,411 funds tracked by Wall St. Rank held AbbVie as of Q2 2020.

Based on Moon Capital Management (Tennessee)'s 13F filing for Q2 2020, filed 24 Aug 2020.